0 581

Cited 3 times in

Increased 18F-FDG Uptake on PET/CT is Associated With Poor Arterial and Portal Perfusion on Multiphase CT

DC Field Value Language
dc.contributor.author윤미진-
dc.contributor.author이민욱-
dc.contributor.author이나래-
dc.contributor.author황상현-
dc.date.accessioned2017-10-26T07:31:35Z-
dc.date.available2017-10-26T07:31:35Z-
dc.date.issued2016-
dc.identifier.issn0363-9762-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/152144-
dc.description.abstractPURPOSE: To correlate 18F-FDG uptake on PET/CT with patterns of arterial and portal perfusion on multi-detector CT (MDCT) in patients with hepatocellular carcinoma (HCC) and to assess the value of variables from PET/CT and MDCT in predicting histological grades and overall survival. METHODS: We retrospectively analyzed MDCT and PET/CT of 66 patients with HCC who underwent surgical treatment. Tumor peak standard uptake value (SUV) was divided by the mean liver SUV (T/LSUV). The mean tumor Hounsfield unit (HU) to mean liver HU was calculated for arterial (T/LHU-A) and portal phases (T/LHU-P). All patients were divided into three groups: I, T/LHU-A ≤l and T/LHU-P <1; II, T/LHU-A >1 and T/LHU-P <1; and III, T/LHU-A >1 and T/LHU-P ≥1. The relationships between the CT perfusion groups and T/LSUV were assessed. Multivariate logistic regression analyses were performed using clinical and imaging parameters for predicting histological grade. Overall survival curves stratified by T/LSUV and CT perfusion groups were estimated using the Kaplan-Meier method. RESULTS: Statistically significant differences in T/LSUV were noted between groups I and II (2.29 [range 1.74-3.60] vs. 1.20 [range 1.07-1.58], P < 0.001) and groups I and III (2.29 [range 1.74-3.60] vs. 1.30 [range 1.07-1.43], P < 0.001). In multivariate analysis, a T/LSUV cutoff of >1.46 was the only independent predictor of tumor grade, with an odds ratio of 8.462 (95% confidence interval 1.799-39.803). Kaplan-Meier curves showed significant differences in OS according to T/LSUV >1.62, group I perfusion pattern, and T/LSUV >1.62 plus group I perfusion pattern (P = 0.04, P = 0.021, and P = 0.002, respectively). CONCLUSION: 18F-FDG PET/CT is not commonly used for detecting HCC due to its limited sensitivity. We found that increased 18F-FDG uptake is associated with decreased arterial and portal perfusion on MDCT. This can be used to preselect patients who would benefit the most from PET/CT. Meanwhile, 18F-FDG uptake remained as the only independent predictor of histological grade, and higher 18F-FDG uptake and lower perfusion pattern on MDCT were significantly related to shorter OS.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherLippincott-
dc.relation.isPartOfCLINICAL NUCLEAR MEDICINE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHCarcinoma, Hepatocellular/diagnostic imaging*-
dc.subject.MESHFemale-
dc.subject.MESHFluorodeoxyglucose F18*-
dc.subject.MESHHumans-
dc.subject.MESHLiver Neoplasms/diagnostic imaging*-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHMultimodal Imaging-
dc.subject.MESHPerfusion Imaging*-
dc.subject.MESHPortal System/diagnostic imaging*-
dc.subject.MESHPositron-Emission Tomography*-
dc.subject.MESHRadiopharmaceuticals*-
dc.subject.MESHTomography, X-Ray Computed-
dc.titleIncreased 18F-FDG Uptake on PET/CT is Associated With Poor Arterial and Portal Perfusion on Multiphase CT-
dc.typeArticle-
dc.publisher.locationUnited States-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Nuclear Medicine-
dc.contributor.googleauthorHwang, Sang Hyun-
dc.contributor.googleauthorLee, Minwook-
dc.contributor.googleauthorLee, Narae-
dc.contributor.googleauthorPark, Saewhan-
dc.contributor.googleauthorKim, Chun Ki-
dc.contributor.googleauthorPark, Mi-Ae-
dc.contributor.googleauthorYun, Mijin-
dc.identifier.doi10.1097/RLU.0000000000001105-
dc.contributor.localIdA04998-
dc.contributor.localIdA02703-
dc.contributor.localIdA02550-
dc.relation.journalcodeJ00595-
dc.identifier.eissn1536-0229-
dc.identifier.pmid26756099-
dc.identifier.urlhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00003072-201604000-00007&LSLINK=80&D=ovft-
dc.contributor.alternativeNameYun, Mi Jin-
dc.contributor.alternativeNameLee, Minwook-
dc.contributor.alternativeNameLee, Na Rae-
dc.contributor.affiliatedAuthorLee, Minwook-
dc.contributor.affiliatedAuthorLee, Na Rae-
dc.contributor.affiliatedAuthorYun, Mi Jin-
dc.citation.volume41-
dc.citation.number4-
dc.citation.startPage296-
dc.citation.endPage301-
dc.identifier.bibliographicCitationCLINICAL NUCLEAR MEDICINE, Vol.41(4) : 296-301, 2016-
dc.date.modified2017-10-24-
dc.identifier.rimsid46923-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Nuclear Medicine (핵의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.